PL1-04: Banning the tobacco  by Park, Jae-Gahb
Copyright © 2007 by the International Association for the Study of Lung Cancer S141
Journal of Thoracic Oncology • Volume 2, Number 8, Supplement 4, August 2007  12th World Conference on Lung Cancer
Among the many measures provided by the Convention there are ﬁve 
key-strategies that are considered as the most cost-effective ones, there-
fore these should be the ﬁrsts into the attention of the countries:
1. Price and tax measures to reduce the demand for tobacco (Article 6 
of WHO FCTC)
2. Protection from exposure to tobacco smoke (Article 8 of WHO 
FCTC)
3. Packaging and labelling of tobacco products (Article 11 of WHO 
FCTC)
4. Ban of tobacco advertising, promotion and sponsorship (Article 13 
of WHO FCTC)
5. Combating illicit trade in tobacco products (Article 13 of WHO 
FCTC).
The success of the WHO Framework Convention on Tobacco Control 
(WHO FCTC) largely depends on preparing countries to ratify the 
treaty and to implement effective tobacco control measures. Building 
and strengthening national capacity (political, managerial and techni-
cal) in countries is the key to a systematic multi-sectoral approach to 
tobacco control. The expected outcome of building national capacity 
is a comprehensive and sustainable national strategy for multi-sectoral 
tobacco control programmes and policies. This approach will ensure 
sustainable governmental and community action for comprehensive 
tobacco control efforts. But capacity building is not only about govern-
ments. It is about mobilizing will and resources wherever they are. The 
process of building capacity in tobacco control needs to go beyond the 
public sector, because it is inherently inﬂuenced by at least two factors 
outside public institutions: the state of governance, and entities in the 
private sector, which include commercial enterprises and civil society 
organizations (tobacco control and cancer prevention organizations, as 
well, professional associations etc.). 
Implementation of the WHO FCTC at country level is not an easy 
process and our experience shows that obstacles can be met in the way. 
There still exists a large unmet capacity gap which needs to be ad-
dressed to enable countries to effectively fulﬁl the above functions for 
national tobacco control. 
The actions to be taken at the country level, as well as the ofﬁcial 
structures that address the core needs for a successful tobacco control 
program, are:
1. Sustainability - an agreed plan of actions, clear long term goals and 
political will; 
2. Comprehensive multi-sectoral tobacco control with governmental 
and community involvement;
3. Local, regional and nation wide activities to ensure awareness rais-
ing and gain support from the public.
As mentioned previously, the clinicians have a key role in this process. 
They reach a high percentage of the population and have the opportu-
nity to help individuals change their behaviour (e.g., cessation support). 
They can inﬂuence peers and colleagues to quit using tobacco. In legis-
lative terms, they can use their inﬂuence at local and national levels to 
encourage adoption of preventative tobacco control measures. Through 
professional societies and associations, they can help strengthen net-
works, set examples and drive social norm change.
While there should be no borders between advocating for cancer preven-
tion and tobacco control, the collaboration between both communities 
- tobacco control and cancer prevention - with the support coming from 
the World Health Organization can truly add value to the “saving lives” 
global effort. How? By educating physicians to promote smoking ces-
sation in their practices, bringing prevention and treatment perspectives 
together more effectively, advocating strongly to inﬂuence both health 
professionals and policy makers, and helping spearhead establishment 
of smoke-free environments in healthcare settings. All these can be done 
through raising awareness among politicians, health professionals and 
society, eventually implementing the WHO FCTC at large. 
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The scientiﬁc and medical evidence is indisputable that tobacco 
products cause great harm not only to their users, but also to nonusers, 
creating devastating health consequences and incalculable economic 
damages in whole world. These adverse effects of tobacco use make 
tobacco control a public health imperative. Active efforts have been 
made in many high-resource countries of Europe, North America and 
Australia to reduce tobacco consumption through a variety of means 
including public health education, banning advertising and promotion, 
increasing prices of tobacco, restricting access of minors to tobacco 
and bans on smoking in public places, bars and restaurants. Despite this 
variety of tobacco control activities, smoking prevalence among adults 
has remained stable at around 20 to 30% in many of these countries 
during past 10 years.
Complete smoking ban may be associated with greater reduction in 
smoking than any other forms of tobacco control measures. It appears 
that legislation banning the manufacture and sale of tobacco products is 
the ultimate step towards total tobacco control. However, legislative ac-
tions for banning tobacco is so difﬁcult to implement immediately that 
comprehensive stepwise and concerted actions are needed. Examples of 
stepwise anti-smoking activities, we implemented in Korea, including 
the international network for banning tobacco, will be presented. 
Since the opening of the National Cancer Center (NCC) in 2000, we 
implemented several anti-smoking policies within our institution and 
initiated nationwide campaigns. We started in 2000 Tobacco-free Work-
place campaign by banning smoking within the boundary of NCC and 
all employees who smoked cigarettes were counseled to quit smoking. 
In 2 years, we achieved the goal of 100% no smoking among our NCC 
employees. In December 2002, we had a ceremony declaring NCC as 
a Total Tobacco-free Workplace to demonstrate the commitment of our 
institution as a commanding post of tobacco-control campaign and to 
exemplify the success of such tobacco-control measures as Tobacco-
free Workplace. We also organized a series of symposia on various 
topics of tobacco control since September 2000. 
Following the approach led by NCC, three major broadcasting compa-
nies in Korea and twelve leading newspapers decided to ban smoking 
scenes or photos in their media in 2004. We contacted labor unions and 
professional organizations in the medical ﬁeld and received full support 
on the non-smoking resolution from the leaders of participating unions 
of the both labor unions in Korea and six medical professional organi-
zations. As the campaign progressed, the Ministry of National Defense 
and the National Police Agency agreed to stop the practice of selling 
duty-free cigarettes to the army from 2009 and the police from 2008. 
Increasing the tobacco tax was proposed in January 31, 2001. Six years 
of determined effort culminated in the attainment of the ultimate goal 
on 22 February 2006 when we ﬁled a petition to the National Assembly 
of Korea, called for a complete ban on the manufacture and sales of 
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tobacco products in next ten years. The purpose of this bill is to protect 
the Korean people from the harmful effects of tobacco use by banning 
the manufacture and sale of tobacco products in the Republic of Korea. 
According to the proposed legislation, no person shall commit acts fall-
ing under any of the following subparagraphs: 
1. An act of manufacturing tobacco products or an act of manufactur-
ing, importing, selling, brokering the sale of, having or holding raw 
material that is used in the production of tobacco products 
2. An act of importing or exporting tobacco products or an act of hav-
ing or holding them for the purposes of importation or exportation 
3. An act of selling or brokering the sale of tobacco products or an act 
of having or holding them in order to sell or broker the sale of them 
4. An act of providing another person with any lands, facilities, ma-
chineries or equipments, funds, transports in order to help him or her 
to commit any offence speciﬁed in the above three subparagraphs of 
this article. 
It is proposed that this Act shall enter into force ten years after the date 
of its promulgation to allow an adequate period of preparation, com-
pensation, decreasing smoking rate, identiﬁcation of substitute sources 
of governmental and provincial tax, and alternative employment for 
tobacco growers, manufacturers, and sales people. 
This effort has received wholehearted support from the international 
community. The Asian National Cancer Center Alliance (ANCCA), the 
organization of National Cancer Centers in Asian countries, which was 
organized in September 2005 resolved to ban the manufacture and sale 
of tobacco products. Also, a meeting of National Cancer Institute Di-
rectors (organized at the International Agency for Research on Cancer 
(IARC) in October 2005) approved the Lyon Declaration which re-
solved to support every initiative to reduce the consumption of tobacco 
products in their countries, and ultimately to reach the complete ban on 
tobacco products.
There has been a widespread recognition on negative effects of smok-
ing in Korea within a relatively short period of time. In Korea, smokers 
were 79.3% of men and 12.5% of women in 1980 and this decreased to 
64.4 % of men and 5.5% of woman in 1996. After raising the price of 
tobacco, smoking prevalence was decreased to 44.1% of men, 2.9% of 
women in 2006. It is hoped that a further decrease in smoking preva-
lence will occur when the act on banning the manufacture and sale of 
tobacco products is enforced. However, it should be emphasized that 
this strategy of reducing tobacco consumption may not achieve its goal 
without international cooperation for tobacco control. 
Because over one billion adults and children are currently addicted 
to toxic tobacco products worldwide, there is no justiﬁable reason to 
permit this industry to continue making, marketing and distributing its 
products as if they were soft drinks. The ultimate goal for the Frame-
work Convention on Tobacco Control should be prohibiting corpora-
tions in the signatory nations from making, marketing and importing all 
tobacco products
We have to continue forming the broad worldwide network for banning 
tobacco, and comprehensive and determined activities of the network 
is achieving positive changes at the local, national, and international 
levels. We will continue to move the Tobacco-free World. 
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The history of this project has been covered in an abstract submitted 
for Educational session 5 and published in the Journal of Thoracic 
Oncology [1]. Additional abstracts in Educational session 5 submitted 
by other speakers will have covered several, additional aspects of the 
project. This abstract will focus upon the recommendations for TNM 
subsets and the stage groupings proposed in our submission to the 
UICC and AJCC. The talk will cover wider aspects of the project, as 
time allows.
The recommendations of the T, N and M descriptors sub-committees 
[2-4], the validation process [5] and the recommendation for the TNM 
subsets and stage groupings [6] will have been published in the Journal 
of Thoracic Oncology prior to the conference
In brief, the recommendations of the T descriptors sub-committee were: 
Subclassify:
• T1 as
 - T1a ( ≤ 2 cm) or
 - T1b (> 2 cm to ≤ 3 cm); and
• T2 as 
 - T2a (>3 to ≤ 5 cm or T2 by other factor and ≤ 5 cm) or
 -  T2b (>5 to ≤ 7 cm).
• Reclassify T2 tumours > 7 cm as T3.
• Reclassify T4 tumours by additional nodule/s in the lung (primary 
lobe) as T3.
• Reclassify M1 by additional nodule/s in the ipsilateral lung (differ-
ent lobe) as T4.
• Reclassify pleural dissemination (malignant pleural or pericardial 
effusions, pleural nodules) as M1.
The recommendations of the N descriptors sub-committee were that the 
existing N descriptors used in the 6th edition of the TNM classiﬁcation 
of lung cancer did not require changes or clariﬁcation.
The recommendations of the M descriptors sub-committee were:
• Reclassify pleural dissemination (malignant pleural effusions, pleu-
ral nodules) from T4 to M1a. 
• Subclassify M1 by additional nodules in the contralateral lung as 
M1a.
• Subclassify M1 by distant metastases (outside the lung/pleura) as 
M1b.
The proposed changes are as follows: 
• Incorporate proposed changes to T and M (affects T2,T3,T4 and M1 
categories). 
